Neurological Diseases and Disorders Weekly
Susan Hasty, Publisher
Table of Contents . . . May 11th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Neurological Diseases and Disorders Weekly | Other Publications
Cerebral Palsy - Treadmill Training Is a Promising Treatment
Parkinson's Disease - Promising New Treatment Proves Safe
Alzheimer's Disease - Protease Inhibitor Could Help Prevent Development
Amyotrophic Lateral Sclerosis - Potential Treatment May Slow Progression of Symptoms
Brain Development - First Genes to Control Cortex Identity Discovered
Brain Injury - Repeated Joint Movements Beneficial in Spastic Hypertonia
Circadian Rhythm - First Enzyme in Mammalian Circadian Clock Identified
Dementia - Smoking Doesn't Prevent Mental Decline
Depression - Researchers Examine Risk Factors for Farmers
Epidemiology - Epilepsy and Febrile Seizures are Serious Problems in Rural Zambia
Epilepsy - Altered Gene Expression in Humans Parallels Observations in Animals
Multiple Sclerosis - Long- and Short-Term Effects of Interferon Modeled in Mice
Neurodegenerative Disease - Fibroblast Growth Factor Regulates Chemokine Receptor in AIDS Patients
Risk Factors - Silent Cerebral Infarction Associated with Increased Pneumonia Risk
Stress Response - Hormone Receptor Identified that Eases Anxiety
Attention Deficit Hyperactivity Disorder - Link to Eye Condition Discovered
Cerebral Dysfunction - Intracranial Gene Transfer May Be Future Therapeutic
Cerebral Vasospasm - Endothelial Nitric Oxide Synthase Gene Transfer Evaluated
Epilepsy - Magnetic Resonance Imaging Reliable for Evaluation
Focal Epilepsy - Imaging Techniques Aid Presurgery Evaluation
Hippocampal Sclerosis - Apoptosis Related to Pyramidal Cell Death
Ischemia-Reperfusion Syndrome - Brain's Neuroprotective Capabilities Increased
Parkinson's Disease - Subthalamic Nucleus Stimulation is an Effective Treatment
Temporal Lobe Epilepsy - Lesional Disease Exhibits Postoperative Memory Deficit
Alzheimer's Disease - FDA Approves Third Medication for AD Treatment
Attention Deficit Hyperactivity Disorder - Compound Will Be Evaluated To Treat (ADHD)
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
